openPR Logo
Press release

Business Opportunities in Cephalosporin Market by 2023

08-22-2018 06:35 PM CET | Health & Medicine

Press release from: Allied Market Research

Cephalosporin Market

Cephalosporin Market

Cephalosporin market was valued at $3,136 million in 2016, and is projected to reach $4,980 million by 2023, growing at a CAGR of 6.8% from 2017 to 2023. The third-generation cephalosporin segment held around one-third share of the total market in 2016.

Get sample copy of this report:https://www.alliedmarketresearch.com/request-sample/3510

The introduction of combination drugs such as multiple antibacterials or antibacterials combined with an inhibitor drives the market growth. The use of combination drugs may decrease the chances of evolution of antibiotic-resistant bacterial strains, which is expected to fuel the growth of the market.

Cephalosporin is a group of semisynthetic, broad-spectrum antibiotics, which is majorly used to treat bacterial infections. The major factors contributing to the growth of the market include increase in incidence of population suffering from pneumonia, tonsillitis, bronchitis, and gonorrhea. In addition, increase in R&D activities to develop highly efficient & safe drugs and upsurge in use of combination therapies further boost the market growth. However, side effects associated with cephalosporin and development of drug-resistant bacterial strains restrain the market growth.

Make purchase enquiry: https://www.alliedmarketresearch.com/purchase-enquiry/3510

Third-generation cephalosporin segment is expected to dominate the market throughout the analysis period, as these have a broader spectrum of activity. Fifth-generation cephalosporin is expected to register highest CAGR of 7.6% during the forecast period.

Key Findings of the Cephalosporin Market:

• Fifth-generation cephalosporin is projected to grow at a CAGR of 15.6% during the forecast period.

• Branded cephalosporin segment is expected to register the highest CAGR of 14.4% during the analysis period.

• Injectable cephalosporin is accounted for more than two-fifths share of the global cephalosporin market in 2016.

• France and Germany collectively contributed for around one-third share of the European cephalosporin market in 2016.

• Japan is the major shareholder, accounting for more than one-third share of the Asia-Pacific cephalosporin market in 2016.

Asia-Pacific is projected to register the highest CAGR of 16.1% during the forecast period, owing to increase in incidence of infectious diseases. In addition, rise in healthcare expenditure is anticipated to offer a lucrative opportunity for the market growth.

Access full summary: https://www.alliedmarketresearch.com/cephalosporin-market

The major companies profiled in the report include Allergan Plc, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Lupin Limited, Merck & Co., Inc., Pfizer Inc., Sanofi, and Teva Pharmaceutical Industries Ltd.

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

Shriram Dighe
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Business Opportunities in Cephalosporin Market by 2023 here

News-ID: 1194888 • Views: 344

More Releases from Allied Market Research

Oncology Information System Market 2020 Size, Share, Growth, Revenue, key player …
The report offers extensive analyses of the key winning strategies, industry dynamics, market size & forecast, and competitive landscape. As per the report, the global oncology information systems market was valued at $2.62 billion in 2017 and is estimated to reach $4.56 billion by 2025, registering a CAGR of 7.1% from 2018 to 2025. Oncology information systems enable management of patient profiles by combining surgical, radiation, and medical oncology information in
Aluminum Chloride Hexahydrate Market: Potential Growth, Analysis, Strategies And …
Allied Market Research published a new report, titled, " Aluminum Chloride Hexahydrate Market: Global Opportunity Analysis and Industry Forecast, 2020 - 2027." The report offers an extensive analysis of key growth strategies, drivers, opportunities, key segment, Porter’s Five Forces analysis, and competitive landscape. This study is a helpful source of information for market players, investors, VPs, stakeholders, and new entrants to gain thorough understanding of the industry and determine steps
Aircraft Cleaning Chemicals Market: Future Scenario and Key Developments, Growth …
Allied Market Research published a new report, titled, " Aircraft Cleaning Chemicals Market: Global Opportunity Analysis and Industry Forecast, 2020 - 2027." The report offers an extensive analysis of key growth strategies, drivers, opportunities, key segment, Porter’s Five Forces analysis, and competitive landscape. This study is a helpful source of information for market players, investors, VPs, stakeholders, and new entrants to gain thorough understanding of the industry and determine steps
Adhesion Promoters Market 2020 Research Report Analysis, Size, Share, Growth, Tr …
Allied Market Research published a new report, titled, " Adhesion Promoters Market: Global Opportunity Analysis and Industry Forecast, 2020-2027." The report offers an extensive analysis of key growth strategies, drivers, opportunities, key segment, Porter’s Five Forces analysis, and competitive landscape. This study is a helpful source of information for market players, investors, VPs, stakeholders, and new entrants to gain thorough understanding of the industry and determine steps to be taken

All 5 Releases


More Releases for Cephalosporin

Cephalosporin Market Expert Reviews & Analysis Along With Study Report 2023
Cephalosporin is a group of semisynthetic, broad-spectrum antibiotics, which is majorly used to treat bacterial infections. The major factors contributing to the growth of the market include increase in incidence of population suffering from pneumonia, tonsillitis, bronchitis, and gonorrhea. In addition, increase in R&D activities to develop highly efficient & safe drugs and upsurge in use of combination therapies further boost the market growth. However, side effects associated with cephalosporin
Cephalosporin Market Strengths, Weaknesses; Key Players Analysis By QYResearchRe …
Qyresearchreports include new market research report “Global Cephalosporin Market Professional Survey Report 2018” to its huge collection of research reports. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering Union Chempharma NCPC Qilu Antibiotics Lupin Pharmaceuticals Hospira Dhanuka Laboratories Fukang Dongying Pharmaceutical Alkem SALUBRIS LIVZON Hetero Drugs CSPC TEVA Download Free exclusive Sample of this report: https://www.qyresearchreports.com/sample/sample.php?rep_id=1548552&type=S The report on the global market for Cephalosporin has been prepared after conducting a fructuous analysis of several industries
Global Cephalosporin Market Specifications, Analysis Forecast 2017 to 2022
Worldwide Market Reports added Latest Research Report titled "Global Cephalosporin Market Professional Survey Report 2018" to its Large Report database. This report studies Cephalosporin in Global Market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share
Global Cephalosporin Drugs Market Professional Survey Report 2017 - 2022
This report studies Cephalosporin Drugs in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. Browse complete report at https://www.researchtrades.com/report/global-cephalosporin-drugs-market-professional-survey-report-2017/1217044 This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering Allergan Astellas Bristol-Myers Squibb GSK Merck Pfizer Sandoz Orchid Company Lupin TEVA HPGC Aurobindo LKPC Alkem CSPC Taj Pharma DHANUKA LABORATORIES CordenPharma SRS Pharmaceuticals Ankur Drugs and Pharma Request for sample
Cephalosporin Market Growing $1,99,754 million by 2023
Cephalosporin is a group of semisynthetic, broad-spectrum antibiotics, which is majorly used to treat bacterial infections. It resembles penicillin and hence is used as an alternative for patients who are allergic to penicillin. It is used in the treatment of a variety of clinical conditions, including pneumonia, skin infections, strep throat, staph infections, tonsillitis, bronchitis, otitis media, and gonorrhea. The global cephalosporin market is estimated to reach $1,99,754 million by
Global Cephalosporin Market Research, Analysis and Overview 2022
Qyresearchreports include new market research report "Global Cephalosporin Market Research Report 2017" to its huge collection of research reports. The exhaustive report here gathers various viewpoints having a place with the general Cephalosporin market which verbalizes the present-day information and future exposures with reference to the dynamic forces at play. The prime purpose for the examination report is to offer the endorser with an expansive layout and make available the beneficial